Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Balsm Alofoq Medical CoSAU:9620 24 ROE % is 4.08% as of Dec. 2025, which is 82% below its 10-year median of 22.08. GuruFocus rates SAU:9620 with a GF Score™ of 24/100. The stock has 4 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Balsm Alofoq Medical Co ranks better than 63.33% on this metric.
Balsm Alofoq Medical Co (SAU:9620) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balsm Alofoq Medical Co ROE % Chart
Balsm Alofoq Medical Co Annual Data
Trend
Dec23
Dec24
Dec25
ROE %
28.92
22.08
6.58
Balsm Alofoq Medical Co Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
ROE %
0.00
19.95
23.14
9.08
4.08
SAU:9620 vs ABT, SYK, MDT: ROE % Comparison
For the Medical Devices subindustry, Balsm Alofoq Medical Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Balsm Alofoq Medical Co ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Balsm Alofoq Medical Co's ROE % distribution charts can be found below:
* The bar in red indicates where Balsm Alofoq Medical Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Balsm Alofoq Medical Co (SAU:9620) has a ROE % of 4.08% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Balsm Alofoq Medical Co and its competitors. This is 82% below median its historical median of 22.08. Over the past decade, Balsm Alofoq Medical Co's ROE % has ranged from 6.55 to 28.92. According to the industry distribution chart, Balsm Alofoq Medical Co ranks #293 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 36.7%.
Is Balsm Alofoq Medical Co's ROE % too high?
Balsm Alofoq Medical Co's current ROE % of 4.08% is 82% below median its 10-year median of 22.08. Over the past 10 years, this metric has ranged from a low of 6.55 to a high of 28.92. The Medical Devices & Instruments industry median ROE % is 2.44. Balsm Alofoq Medical Co's value of 4.08% is 67.2% above this industry median. Based on the distribution chart, Balsm Alofoq Medical Co ranks #293 out of 799 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Balsm Alofoq Medical Co has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Balsm Alofoq Medical Co's ROE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Balsm Alofoq Medical Co ranks #293 out of 799 companies for ROE %. This puts Balsm Alofoq Medical Co in the upper half of its industry. The industry median ROE % is 2.44. Balsm Alofoq Medical Co's value of 4.08% is 67.2% above this benchmark. Historically, Balsm Alofoq Medical Co's own ROE % has ranged from 6.55 to 28.92 over the past decade. While the company's 10-year median is 22.08 vs. the industry median of 2.44, Balsm Alofoq Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.44, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Balsm Alofoq Medical Co's current ROE % of 4.08% is 67.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Balsm Alofoq Medical Co and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Balsm Alofoq Medical Co's current ROE % is 4.08%, which is 82% below median its own 10-year median of 22.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balsm Alofoq Medical Co stock overvalued right now?
Balsm Alofoq Medical Co (SAU:9620) has a current ROE % of 4.08%. The current ROE % is 4.08%, which is 82% below median its 10-year median of 22.08 and 67.2% above the Medical Devices & Instruments industry median of 2.44. Balsm Alofoq Medical Co's overall GF Score™ is 24/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Balsm Alofoq Medical Co (SAU:9620), the current ROE % is 4.08% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Balsm Alofoq Medical Co operates in the medical sector. Its activities include medical services, specialized clinics and medical complexes, medical operations, and the import and supply of medical devices and supplies to all regions of the Kingdom of Saudi Arabia.
24GF Score
Get the complete analysis for SAU:9620
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9620 has been successfully added to your 
